Image de couverture de livre

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Cong Dai, Yu‐Hong Huang, Min Jiang
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Alimentary Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease—Authors' Reply
par: Isabel Carbery, et autres
Publié: (2024)

Meta‐Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease
par: Quinn Goddard, et autres
Publié: (2025)

Letter: Incremental Value and Outcome Modelling in Frailty Assessment for Older Patients With Inflammatory Bowel Disease
par: Chang Liu, et autres
Publié: (2026)

Letter: Incremental Value and Outcome Modelling in Frailty Assessment for Older Patients with Inflammatory Bowel Disease. Author's Reply
par: A. B. Fons, et autres
Publié: (2026)

Letter: Allostatic Load and Adverse Prognosis in Inflammatory Bowel Disease—Need More Evidence. Authors' Reply
par: Jianhui Zhao, et autres
Publié: (2024)

Meta‐Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel Disease
par: Purab Patel, et autres
Publié: (2025)

Mild Endoscopic Disease Activity Is Associated With Adverse Outcomes Among Older Adults With Inflammatory Bowel Disease
par: Catherine Z. Tang, et autres
Publié: (2025)

Meta‐Analysis: Pregnancies With Inflammatory Bowel Disease Complicated by Intrahepatic Cholestasis of Pregnancy
par: Shamim Joudaki, et autres
Publié: (2025)

Frailty Is Associated With All‐Cause and Acute Hospitalisations During 18 Months Follow‐Up in Older Patients With Inflammatory Bowel Disease
par: Anne B. Fons, et autres
Publié: (2026)

Systematic Review: Stigma Associated With Inflammatory Bowel Disease
par: Suprabhat Giri, et autres
Publié: (2025)

Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity
par: Brigida Barberio, et autres
Publié: (2026)

Letter: From Descriptive Epidemiology to Clinical Imperative—Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease
par: DuJiang Yang, et autres
Publié: (2025)

Editorial: Optimal Treatment for Older Patients With Inflammatory Bowel Disease: How to Detect and Manage Frailty? Authors' Reply
par: A. B. Fons, et autres
Publié: (2026)

Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story?
par: Liang Jiao, et autres
Publié: (2026)

Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease—Authors' Reply
par: Jessica D. Lee, et autres
Publié: (2025)

Prevalence and Predictors of Symptoms of Anxiety or Depression at Diagnosis in Patients With Inflammatory Bowel Disease: An Inception Cohort
par: Christy Riggott, et autres
Publié: (2025)

Letter: Critical Insights on a Nationwide Cohort Study of Inflammatory Bowel Disease, Histological Activity and Fracture Risk
par: Saad Khan, et autres
Publié: (2024)

Editorial: Allostatic Load and Inflammatory Bowel Disease
par: Jeli Mendoza, et autres
Publié: (2024)

Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story? Authors' Reply
par: Sanjay K. Murthy
Publié: (2026)

Letter: Bowel Preparation Quality in Patients With Crohn's Disease
par: Tamar Schildkraut, et autres
Publié: (2024)

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination
par: Yash Hegde, et autres
Publié: (2026)

Editorial: Are Antidepressant Medications Safe in Inflammatory Bowel Disease?
par: Matthew D. Coates, et autres
Publié: (2025)

Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease
par: Marco Vincenzo Lenti, et autres
Publié: (2025)

Editorial: Can We Prevent Inflammatory Bowel Disease?
par: Agnes Hiu Yan Ho, et autres
Publié: (2025)

Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply
par: Jianhui Zhao, et autres
Publié: (2024)

Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
par: Uma Mahadevan, et autres
Publié: (2025)

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Authors' Reply
par: Anupam Kumar Singh, et autres
Publié: (2026)

Letter: Bowel Preparation Quality in Patients With Crohn's Disease—Authors' Reply
par: Virginia Solitano, et autres
Publié: (2024)

Steatotic Liver Disease Prevalence in China: A Population‐Based Study and Meta‐Analysis of 17.4 Million Individuals
par: Zhenqiu Liu, et autres
Publié: (2025)

Editorial: Can We Prevent Inflammatory Bowel Disease? Authors' Reply
par: Fai Fai Ho, et autres
Publié: (2025)

Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers—A Conundrum That Continues
par: Stephanie Gold, et autres
Publié: (2025)

Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease: Authors' Reply
par: Suprabhat Giri, et autres
Publié: (2025)

Editorial: Are Antidepressant Medications Safe in Inflammatory Bowel Disease? Authors' Reply
par: Bharati Kochar, et autres
Publié: (2025)

Editorial: Managing the Moving Target—Dose Adjustments in Inflammatory Bowel Disease
par: Nicholas Clark, et autres
Publié: (2025)

Prescribing Inflammatory Bowel Disease Medications in Chronic Kidney Disease: A Practical Guide
par: Lynna Chen, et autres
Publié: (2025)

Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet?
par: Joyce Wing Yan Mak
Publié: (2025)

Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
par: Soroor Owrangi, et autres
Publié: (2024)

Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease
par: Jessica D. Lee, et autres
Publié: (2025)

Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel Diseases
par: Dhruv Ahuja, et autres
Publié: (2025)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer
par: Alexandra Hickey, et autres
Publié: (2025)